Search Weight Loss Topics:

Page 60«..1020..59606162..»

Category Archives: Testosterone

The Good, the Bad and the Ugly of UFC on ESPN 6 – Sherdog.com

Posted: October 23, 2019 at 9:41 pm

Lauzon turned back time by defeating JonathanPearce. It was the perfect way to say goodbye to the sport forLauzon, who has sustained a great deal of damage over the course ofhis career and stepped into the cage riding a three-fight losingstreak. In front of his beloved Bostonians and with the samesignature violence that makes him a surefire Hall of [emailprotected]#$%&gAwesome candidate, Lauzon big-brothered the up and comer withground-and-pound from a half nelson. While Lauzon was hesitant tocommit to retirement immediately after the fight, UFC PresidentDana White seemed ready to encourage him to end his career on ahigh note. Lauzon turned what looked like a setup match for thenext generation -- Pearce was on a five-fight winning streak thatincluded an appearance on Dana Whites Contender Series and twoothers in Bellator MMA -- into the perfect swan song.

Rosa and Costa entered the arena hoping to the right ship, as bothmen had experienced defeats in their previous outings. In stylepairings that promised fireworks against MannyBermudez and the ironically named BostonSalmon, Rosa and Costa came out in the winning side of thosefireworks. With the exception of KyleBochniak, who was outclassed by an impressively poised SeanWoodson, the city managed to enjoy home-cooked victories. Whilethe UFC has rightfully received criticism for not booking mainevents in locations more appropriate for the fighters, it does agood job of keeping a local feel to the undercards. Results likethis help elevate an otherwise routine event.

Unfortunately for Weidman, the extra 20 pounds on the scale didnothing to resuscitate his career. Reyes heavy hands and technicalacumen proved too steep of a mountain to climb, as the formerchampion fell victim to a backstepping left hand and follow-uphammerfists on the ground. Less than two minutes into the contest,Weidmans light heavyweight campaign came to a screeching halt. Hadthings gone differently, it seemed almost certain that theSerra-Longo Fight Team standout would have been tapped to standopposite Jon Jones in abattle over the light heavyweight title. Say what you will aboutwho would have been favored to win that fight, but Weidman wouldhave added name value to the blue corner that is not readilyavailable at 205 pounds. Similar to when rumors swirled aboutRockhold being fast tracked if he passed his first test in a higherweight class, the potential involving Weidman went unfulfilled andthe dominant champion was left to look elsewhere for a marqueematchup.

A victory over Reyes would have provided a simple answer to thequestion of what was next for Weidman, along with a built-in chanceto redeem the misfortune that has plagued his career in recentyears. Now, another decisive loss puts that question in bold print.There just is not an easy answer for Weidman at this point. Hecould elect to remain at 205 pounds. However, his ceiling seemspretty obvious. The damage he sustained in wars at 185 pounds didnot just magically go away with a move up in weight. Just like wewitnessed with James Vick atUFC Fight Night 161, the leap in weight may have come too late.Should Weidman decide to run it back at middleweight, he will facethe same challenges associated with his inability to absorbpunishment. The top names in the division would be no kinder to hischin, including KelvinGastelum, who managed to hurt Weidman badly before beingsubmitted two years ago. Plus, Weidman would be back to draininghis large frame again.

It seems likely that Weidman and his team will examine what lifeoutside of competition looks like. After being knocked out fivetimes in six fights and nearly suffering the same fate in his lonevictory during that stretch, it looks like we are witnessing theend of a great career.

Hardy has made four appearances inside the Octagon so far. Half ofthose them have gotten bogged down with rule-bending controversy.From a competitive standpoint, those controversies have distractedfrom his clear growth as a fighter under the direction of AmericanTop Team. Now, his taking two puffs from a prescribed inhalerbetween the second and third rounds has taken the conversation awayfrom the things he did right in the cage in Boston.

By adding more elements to his game, Hardy managed to outpoint thestubborn Ben Sosoli.Leg kicks from the outside, effective defensive footwork and theability to do something other than quickly blast his opponent tobits were on display. However, when he used his medication betweenrounds, it called the entire fight into question. Going thedistance for the first time and handling a consistent pace withoutmuch issue would normally something to commend for a fighter whosecareer mainly consists of short circuiting the opposition in quickfashion. How can we rightfully look at Hardy lasting the full 15minutes as a positive if he needed his asthma medication to doso?

The fault does not exclusively rest with Hardy or trainer Din Thomas,who was the primary target of Whites criticism after the fact.Granted, when most athletic commissions only allow water or in somecases an electrolyte-enhanced beverage like Gatorade in the corner,there is no reason to believe that medication that enhancescardiorespiratory function is permissible during a fight. However,the Massachusetts State Athletic Commission did plainly tell Hardyand his team that it was permitted. The level of confusion betweenthe commission (which quickly overturned the decision to ano-contest), UFC Vice President of Regulatory Affairs Marc Ratner,the commentary booth, media and amateur online investigators wastruly bizarre to witness. Is Albuterol allowed between rounds? Whatabout the potential abuse of asthma medication in relation tosports performance? Is Massachusetts clear enough about what is andis not allowed in competition? Why was the fight allowed tocontinue into that pivotal third frame in the first place?

As the infamous 1983 boxing match between Luis Resto and BillyCollins Jr. showed, asthma medication can be used a PED to increasecardio capacity. As the testosterone replacement therapy era of MMAshowed, fighters can and will abuse the use of therapeuticexemptions to gain a competitive edge. It sounds like a recipe fordisaster if the commission does not address this properly.

Clear improvement and two dominant wins from Hardy have beensandwiched between two displays of poor judgment. Those trustedwith overseeing the action in a responsible fashion get a solidfailing grade on clearly communicating the proper rules andhandling discrepancies as they arise. Once again, Hardysperformance inside the cage was overshadowed by other factors.

See the original post here:
The Good, the Bad and the Ugly of UFC on ESPN 6 - Sherdog.com

Posted in Testosterone | Comments Off on The Good, the Bad and the Ugly of UFC on ESPN 6 – Sherdog.com

Testosterone Replacement Therapy Market to Expand at a Healthy 4.2% CAGR from 2016 to 2024 – Statsflash

Posted: October 23, 2019 at 9:41 pm

The global testosterone replacement therapy market rides on the back of technology. As consumer focus shifts from access to comfort, players in the market for testosterone replacement therapy are looking at new opportunities to capitalize on the potential. This exclusive report from Transparency Market Research will take you through an extensive analysis of every aspect in the testosterone replacement therapy market that is critical for defining your success strategy. It offers prudent information on markets under currents, trends that will open new doors, factors that will remain important, challenges that need to be overcome, prevailing competition in the market, and the geographical landscape.

Based on a tested and proven research methodology, our research analysts bring to you fact-checked information. Besides presenting the current market figures, our analysts provide you with accurate forecasts that can be the game-changer for your winning strategies for tomorrow. On the other hand, our reports also offer tailor-made insights. Further, our reports are packed with experts viewpoints which are transcribed from interviews conducted by our analysts.

For Right Perspective & Competitive Insights, Request For A Sample Here

For every market, information on leading players can be the difference between success and failure, be it a prominent brand or not. Our reports cover every significant players in the global testosterone replacement therapy market providing information about the company profile, products, winning strategies and market revenues. Not just that, TMR also provides information on the competitive landscape, helping you understand what impacted in one company being the market leader and others not. It also explains on the companies imperatives that define their success in the global market for testosterone replacement therapy.

Healthcare, unlike most industries, is typical of the region. Humans have multiple races and hence their genetic makeups are different. As a result, one condition has different impacts depending on the region. Therefore, information on how consumer requirements are different in regional landscape of the global testosterone replacement therapy is provided her in the report. Further, the economic capabilities of a country has a huge impact on healthcare infrastructure. TMRs report analysis the current economic scenario and also brings to you information on affordability during the coming years.

To Clarify Your Doubts About The Report, Request A Brochure Here

From market share to region-specific strategies, the report covers it all. At the same time, players in the testosterone replacement therapy market who are looking to expand might want to assess the potential of a prospective region. Our reports can provide you with custom-made insights for specific regions in the global testosterone replacement therapy market. The geographical analysis also covers regions-specific factors that could turn out to be hurdle for growth in the coming years.

Read the original here:
Testosterone Replacement Therapy Market to Expand at a Healthy 4.2% CAGR from 2016 to 2024 - Statsflash

Posted in Testosterone | Comments Off on Testosterone Replacement Therapy Market to Expand at a Healthy 4.2% CAGR from 2016 to 2024 – Statsflash

How to enjoy sex during the menopause – Yahoo Lifestyle

Posted: October 23, 2019 at 9:41 pm

The menopause brings everything from hot flushes and night sweats to insomnia and mood swings.

But its affect on a womans sex life is less commonly discussed.

Going through the change often triggers vaginal dryness, which can make intercourse agonising.

Hormonal changes combined with sleepless nights and embarrassment over the middle age spread also puts many off being intimate.

With today marking World Menopause Day, Yahoo UK asks experts how women can continue to enjoy sex while going through the change.

Menopause usually strikes between 45 and 55, however, one in 100 women experience symptoms at under 40, NHS statistics show.

Most endure symptoms for around four years, but one in 10 battle the discomfort for up to 12 years.

While many blush at the thought of vaginal dryness, menopause specialist nurse Kathy Abernethy warns it is almost an inevitability.

Vaginal dryness comes about when the cells in the vagina change, she told Yahoo UK. The vagina is like a sponge; it gives during intercourse. Menopause makes it become rigid.

Vaginal dryness puts many menopausal women off sex. [Photo: Getty]

The uncomfortable symptom affects a womans day-to-day life, with many enduring pain and itching when they walk or exercise. When it comes to sex, vaginal dryness can be agonising.

It feels like sandpaper, Ms Abernethy said. You get a friction feeling when the penis should just glide in.

READ MORE: 10 of the best menopause relief products

While uncomfortable for all, gynaecologist Dr Michael Savvas warns young menopausal women may particularly suffer.

Hormone levels drop off more steeply in menopausal women under 40, he told Yahoo UK. Its unnatural for a young woman to have low oestrogen or testosterone.

While it may sound bleak, menopausal women do not have to wave goodbye to their sex lives.

It's important to communicate with your partner that its an issue, Ms Abernethy said.

Lots of women are suffering in silence. Sex is not an open conversation but men dont get it until theyre told.

Being open with your other half may also stop them blaming themselves, with many men feeling shunned when their partner turns down their advances, Ms Abernethy said.

When it comes to enjoying sex again, ramping up foreplay will not solve the problem.

READ MORE: Moody? Tired? Forgetful? You may be peri-menopausal even in your 30s!

Ms Abernethy recommends women opt for vaginal lubricants, which can be bought on the high street.

Some may also benefit from the hormonal replacement therapy (HRT) vaginal oestrogen, which can come as a pessary, cream or vaginal ring. Unlike other forms of HRT, vaginal oestrogen has not been linked to cancer or blood clots.

Although both lubricants and vaginal HRT are effective, they do not cure vaginal dryness, with women relying on the treatments every time they have sex.

For the best results, it is important women seek help as soon as they experience discomfort.

Vaginal dryness doesnt get better on its own; treatment is required, Ms Abernethy said.

Eating a diet rich in plant-based oestrogen may also help. Speaking to Yahoo UK, Tania Adib - a consultant gynaceologist at The Medical Chambers Kensington - recommended chickpeas, nuts and seeds.

Limit your intake of alcohol as drinking over the safe recommended limit can lower oestrogen levels and lead to vaginal dryness as a result, she added.

While vaginal dryness stops some menopausal women being intimate, for others, a low sex drive means they simply do not want to.

Reduced libido affects lots of women, Ms Abernethy said.

Hormonal changes are often to blame, with testosterone, which gives a woman her sex drive, falling during the change.

It could also be caused by the ageing process, Ms Abernethy said. Women feel less sensual than they did when they were younger.

Menopause symptoms like insomnia also leave women exhausted and not in the mood. And relationships can get stale in middle age.

Hormonal changes and ageing also trigger abdominal weight gain, which often leaves women with low self esteem.

To get back in the mood, Ms Abernethy first recommends women make sex comfortable, via lubricants or other treatments.

Testosterone therapies can then help them feel more passionate. Testosterone is not licensed for use in women in the UK, however, doctors can give it off label.

READ MORE: The menopause timeline: What to expect from each stage

Doctors prescribe products licensed for men at a much reduced dose, Dr Savvas said.

When given appropriately, very few develop male characteristics, like facial hair, he added.

As well as getting women in the mood, testosterone may also help women enjoy intercourse.

Many report finding sex less pleasurable and finding it hard to orgasm, testosterone helps, Dr Savvas said.

Vaginal oestrogen aside, the medic also recommends often forms of HRT, like tablets, patches and implants.

The treatment has hit the headlines over the years after links to breast, ovarian and womb cancer.

According to Dr Savvas, however, HRT is extremely safe, particularly for those with no personal or family history of disease.

In early-onset menopause, HRT could even keep women healthy, he adds. Experiencing the change too soon can trigger osteoporosis and heart disease, with oestrogen being linked to both bone and cardiovascular health.

For some, their libido returns post-menopause, but Ms Abernethy stresses a womans attitude to ageing is important.

If youre hankering after a 20 year old's body, it's not going to happen, she said. You should accept your 50-year-old body is still hugely attractive to your partner.

To break down the stigma around sex during the menopause, Ms Abernethy urges people to discuss it more openly.

Menopause is a natural part of our lives, she said. It should be talked about.

Read the rest here:
How to enjoy sex during the menopause - Yahoo Lifestyle

Posted in Testosterone | Comments Off on How to enjoy sex during the menopause – Yahoo Lifestyle

Global Testosterone Replacement Therapy Market Industry: A Latest Research Report to Share Market Insights and Dynamics – Healthcare News

Posted: October 17, 2019 at 8:42 pm

Testosterone Replacement Therapy Market presents a detailed competitive outlook and systematic framework of testosterone replacement therapy market at a global uniform platform. The report commences with the market summary, chain structure, past and present market size in conjunction with business opportunities in coming back years, demand and lack, numerous operators and restrainers. The research study exhibits the historical data that analyzes respective analytical tools including porters five forces analysis, supply chain analysis, pricing analysis, and regulatory analysis. It offers a detailed analysis of top-line vendors along with revenue and cost-profit analysis.

Testosterone Replacement Therapy Market reports provide 10 years pre-historic and forecast for the sector and involve data on socio-economic data of global. Key stakeholders can analyze statistics, tables & figures mentioned in this report for strategic planning which lead to the success of the organization.Testosterone Replacement Therapy Market reports provide a comprehensive overview of the global market size and share. Global testosterone replacement therapy Market report provides strategists, marketers and senior management with the critical information they need to assess the global testosterone replacement therapy sector.

Get Sample For Technological Breakthroughs (Use Company eMail ID to Get Higher Priority) at: https://market.us/report/testosterone-replacement-therapy-market/request-sample/

Research study helps to examine the change in market dynamics, geographical market volume, technological innovations, and testosterone replacement therapy business opportunities in the coming years. The research covers a crucial market segmentation analysis that is a rich source of all essential segments including testosterone replacement therapy types, applications, technologies, end-users, and territories. It provides key essentials for equipment suppliers, education & research institutes, developing companies, research experts, service providers, operators, and investors. It enables industry players to target the demands and preferences of their consumers and achieves the market competitive advantage by targetting different customers and target specific products to meet their demands. The report presents up to and coming data beside fundamental insights associated with the market estimate over a time frame, from 2020 to 2029.

Global Testosterone Replacement Therapy Market Key Manufacturers:

AbbVieEndo InternationalEli lillyPfizerActavis (Allergan)BayerNovartisTevaMylanUpsher-SmithFerring PharmaceuticalsKyowa KirinAcerus Pharmaceuticals

Global Segmentation Analysis 2029:

Global Testosterone Replacement Therapy Market research supported Product sort includes:

GelsInjectionsPatches

Global Testosterone Replacement Therapy Market research supported Application Coverage :

HospitalsClinics

Leading Market Regions:

Center East and Africa Testosterone Replacement Therapy Market (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)

North America Testosterone Replacement Therapy Market (United States, Canada, Mexico)

Asia Pacific Testosterone Replacement Therapy Market (China, Japan, Korea, India, Southeast Asia)

South America Testosterone Replacement Therapy Market (Brazil, Argentina, Colombia)

Europe Testosterone Replacement Therapy Market (Germany, UK, France, Russia, Italy)

Place An Inquiry Before Investment (Use Corporate Details Only):https://market.us/report/testosterone-replacement-therapy-market/#inquiry

Some Notable Report Offerings

1. Introduction of testosterone replacement therapy with progress and situation in the market.

2. The production technique of testosterone replacement therapy along with research and patterns observed.

3. Study of international testosterone replacement therapy market top producers, including Company Profile, Information about commodities, manufacturer data, and Contact Information.

4. Scrutiny of Global testosterone replacement therapy market potential, opportunities, costing of production, price, and revenue.

5. Survey of testosterone replacement therapy Market with Comparison, Deployment, Usage, and Import and Export.

6. testosterone replacement therapy market Survey with Market Condition from a competitive edge by means of Companies and Regions.

7. 2020-2029 Market Anticipation of International testosterone replacement therapy Market with Value, Earnings, Market Segments, Supply, Requirement, Import, and Export.

8. Current factors affecting the market sectors of APAC, Europe, North America, and South America.

9 .testosterone replacement therapy Market Analysis of Industry Chain Pattern, Primary Resources, manufacturing sector.

10. Consequently, the report probes the international crucial testosterone replacement therapy market leaders thoroughly.

View Details of Testosterone Replacement Therapy Market Research Report,click the link Here: https://market.us/report/testosterone-replacement-therapy-market/

About Us:Market.us offers its clients a one-stop solution platform for all market research needs. Our focus on custom research, consulting projects, syndicate reports covers a variety of industries, sectors, and verticals, and we cover niche market titles, and we also cater to client-specific requirements. Analysts at Market.us have access to large databases of statistical information, Customs Import and Export Database, Industry Association Database, etc., besides expert resources and participants. Our expert panel includes specialists in industries and sectors such as energy, automotive, chemicals, healthcare, medical, ICT consumer goods, banking & finance, mining & minerals, food and beverages, agriculture and other related fields, aerospace, machinery & equipment, etc., apart from professional survey teams and competent teams of data analysts and researchers.

Get in Touch with Us :

Mr. Benni Johnson

Market.us (Powered By Prudour Pvt. Ltd.)

Send Email: inquiry@market.us

Address: 420 Lexington Avenue, Suite 300 New York City, NY 10170, United States

Tel: +1 718 618 4351

Website: https://market.us

Original post:
Global Testosterone Replacement Therapy Market Industry: A Latest Research Report to Share Market Insights and Dynamics - Healthcare News

Posted in Testosterone | Comments Off on Global Testosterone Replacement Therapy Market Industry: A Latest Research Report to Share Market Insights and Dynamics – Healthcare News

Testosterone Replacement Therapy Market: An Insight on the Important Factors and Trends Influencing the Market – Online News Guru

Posted: October 17, 2019 at 8:42 pm

The globalmarket for testosterone replacement therapyis characterized by the presence of a large number of small and large scale manufacturers. All of the manufacturers have been steadfast in filling the meagre market gap in order to enhance their prospects of growth. Furthermore, research and development has been the central characteristic of al the market players operating in the global market.

In 2015, it was found that 80% of the total market share was held by the top five market vendors with AbbVie Inc. taking the lead. The large scale vendors are focusing on establishing an iconic brand for their product by resorting to rigorous marketing and advertising tactics. The smaller companies are expected to concentrate on capturing the local and regional markets to sustain themselves in the current scenario of stiff competition.

A negative implication for the leading market players in recent times has been the loss of patents for their products. This has not only plundered them of revenues but has also affected the workflow of these companies. The market players are expected to launch awareness campaigns about testosterone replacement therapies in order to educate and inform the consumers. Hence, the market for testosterone replacement therapies is expected to witness the emergence of several new trends and opportunities over the forthcoming years. Some of the key players in the global testosterone replacement therapy market include Bayer AG, Endo Pharmaceuticals, Inc., Novartis AG, and Allergen plc.

Get Sample with Latest Research @https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1097

The CAGR for theglobal testosterone replacement therapy marketis estimated to be -4.20% over the period between 2016 and 2024. The negative growth rate of the global market is expected to take the market value from US2.0 bn in 2015 to a decreased value of US$1.3 bn by 2024-end.

High Incidence of Hypogonadism to Drive Market Demand

Research studies suggest that around 30% of all men suffer from testosterone deficiency, which has driven demand within the global market for testosterone replacement therapy. Furthermore, the population demographic of men in the age range of 40-79 years is more likely to suffer from testosterone deficiency. The need for mutation or having an offspring amongst men in the aforementioned age range has driven demand within the global market. Moreover, the geriatric population has been on a rise, which underhandedly contributes to market growth. Several campaigns aimed at educating people about the benefits of testosterone replacement therapy have been an important propeller of demand within the global market. It is anticipated that more people suffering from testosterone deficiency would resort to these therapies over the coming years.

Enquiry for Discount on this Report @https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1097

Side Effects of Testosterone Replacement Therapy Could Obstruct Market Growth

Despite the rising awareness amongst the masses about the advantages of testosterone replacement therapies, the market growth is hindered by the apprehension of the people. The chances of developing metabolic disorders are higher in men who undergo testosterone replacement therapies. Furthermore, the risk of developing cardiovascular diseases also discourages people from resorting to testosterone replacement therapies. The FDA has also cautioned people about the use of such therapies by issuing strict warnings, which has further obstructed the growth of the global market.

See the article here:
Testosterone Replacement Therapy Market: An Insight on the Important Factors and Trends Influencing the Market - Online News Guru

Posted in Testosterone | Comments Off on Testosterone Replacement Therapy Market: An Insight on the Important Factors and Trends Influencing the Market – Online News Guru

How to enjoy sex during the menopause – Yahoo News UK

Posted: October 17, 2019 at 8:42 pm

Many women battle hot flushes during the menopause. [Photo: Getty]

The menopause brings everything from hot flushes and night sweats to insomnia and mood swings.

But its affect on a womans sex life is less commonly discussed.

Going through the change often triggers vaginal dryness, which can make intercourse agonising.

Hormonal changes combined with sleepless nights and embarrassment over the middle age spread also puts many off being intimate.

With today marking World Menopause Day, Yahoo UK asks experts how women can continue to enjoy sex while going through the change.

Menopause usually strikes between 45 and 55, however, one in 100 women experience symptoms at under 40, NHS statistics show.

Most endure symptoms for around four years, but one in 10 battle the discomfort for up to 12 years.

While many blush at the thought of vaginal dryness, menopause specialist nurse Kathy Abernethy warns it is almost an inevitability.

Vaginal dryness comes about when the cells in the vagina change, she told Yahoo UK. The vagina is like a sponge; it gives during intercourse. Menopause makes it become rigid.

The uncomfortable symptom affects a womans day-to-day life, with many enduring pain and itching when they walk or exercise. When it comes to sex, vaginal dryness can be agonising.

It feels like sandpaper, Ms Abernethy said. You get a friction feeling when the penis should just glide in.

READ MORE: 10 of the best menopause relief products

While uncomfortable for all, gynaecologist Dr Michael Savvas warns young menopausal women may particularly suffer.

Hormone levels drop off more steeply in menopausal women under 40, he told Yahoo UK. Its unnatural for a young woman to have low oestrogen or testosterone.

While it may sound bleak, menopausal women do not have to wave goodbye to their sex lives.

It's important to communicate with your partner that its an issue, Ms Abernethy said.

Lots of women are suffering in silence. Sex is not an open conversation but men dont get it until theyre told.

Being open with your other half may also stop them blaming themselves, with many men feeling shunned when their partner turns down their advances, Ms Abernethy said.

When it comes to enjoying sex again, ramping up foreplay will not solve the problem.

READ MORE: Moody? Tired? Forgetful? You may be peri-menopausal even in your 30s!

Ms Abernethy recommends women opt for vaginal lubricants, which can be bought on the high street.

Some may also benefit from the hormonal replacement therapy (HRT) vaginal oestrogen, which can come as a pessary, cream or vaginal ring. Unlike other forms of HRT, vaginal oestrogen has not been linked to cancer or blood clots.

It is also only applied at the time of sex and doesnt enter the bloodstream, Ms Abernethy said.

Although both lubricants and vaginal HRT are effective, they do not cure vaginal dryness, with women relying on the treatments every time they have sex.

For the best results, it is important women seek help as soon as they experience discomfort.

Vaginal dryness doesnt get better on its own; treatment is required, Ms Abernethy said.

Eating a diet rich in plant-based oestrogen may also help. Speaking to Yahoo UK, Tania Adib - a consultant gynaceologist at The Medical Chambers Kensington - recommended chickpeas, nuts and seeds.

Limit your intake of alcohol as drinking over the safe recommended limit can lower oestrogen levels and lead to vaginal dryness as a result, she added.

While vaginal dryness stops some menopausal women being intimate, for others, a low sex drive means they simply do not want to.

Reduced libido affects lots of women, Ms Abernethy said.

Hormonal changes are often to blame, with testosterone, which gives a woman her sex drive, falling during the change.

It could also be caused by the ageing process, Ms Abernethy said. Women feel less sensual than they did when they were younger.

Menopause symptoms like insomnia also leave women exhausted and not in the mood. And relationships can get stale in middle age.

Hormonal changes and ageing also trigger abdominal weight gain, which often leaves women with low self esteem.

To get back in the mood, Ms Abernethy first recommends women make sex comfortable, via lubricants or other treatments.

Testosterone therapies can then help them feel more passionate. Testosterone is not licensed for use in women in the UK, however, doctors can give it off label.

READ MORE: The menopause timeline: What to expect from each stage

Doctors prescribe products licensed for men at a much reduced dose, Dr Savvas said.

When given appropriately, very few develop male characteristics, like facial hair, he added.

As well as getting women in the mood, testosterone may also help women enjoy intercourse.

Many report finding sex less pleasurable and finding it hard to orgasm, testosterone helps, Dr Savvas said.

Vaginal oestrogen aside, the medic also recommends often forms of HRT, like tablets, patches and implants.

The treatment has hit the headlines over the years after links to breast, ovarian and womb cancer.

According to Dr Savvas, however, HRT is extremely safe, particularly for those with no personal or family history of disease.

In early-onset menopause, HRT could even keep women healthy, he adds. Experiencing the change too soon can trigger osteoporosis and heart disease, with oestrogen being linked to both bone and cardiovascular health.

For some, their libido returns post-menopause, but Ms Abernethy stresses a womans attitude to ageing is important.

If youre hankering after a 20 year old's body, it's not going to happen, she said. You should accept your 50-year-old body is still hugely attractive to your partner.

To break down the stigma around sex during the menopause, Ms Abernethy urges people to discuss it more openly.

Menopause is a natural part of our lives, she said. It should be talked about.

View post:
How to enjoy sex during the menopause - Yahoo News UK

Posted in Testosterone | Comments Off on How to enjoy sex during the menopause – Yahoo News UK

Reviewing AbbVie Inc. (ABBV)’s and Eli Lilly and Company (NYSE:LLY)’s results – MS Wkly

Posted: October 17, 2019 at 8:42 pm

This is a contrast between AbbVie Inc. (NYSE:ABBV) and Eli Lilly and Company (NYSE:LLY) based on their profitability, analyst recommendations, risk, dividends, institutional ownership, earnings and valuation. The two companies are Drug Manufacturers Major and they also compete with each other.

Valuation and Earnings

Table 1 shows gross revenue, earnings per share and valuation of the two companies. Eli Lilly and Company is observed to has lower earnings, but higher revenue than AbbVie Inc. When business has lower price-to-earnings means it is more affordable than its counterpart presently. AbbVie Inc. is trading at a lower price-to-earnings ratio than Eli Lilly and Company, indicating that it is presently more affordable of the two stocks.

Profitability

Table 2 provides AbbVie Inc. and Eli Lilly and Companys net margins, return on equity and return on assets.

Risk and Volatility

AbbVie Inc. has a beta of 0.92 and its 8.00% less volatile than Standard & Poors 500. Competitively, Eli Lilly and Companys beta is 0.18 which is 82.00% less volatile than Standard & Poors 500.

Liquidity

The Current Ratio and a Quick Ratio of AbbVie Inc. are 1 and 0.9. Competitively, Eli Lilly and Company has 1.1 and 0.8 for Current and Quick Ratio. Eli Lilly and Companys better ability to pay short and long-term obligations than AbbVie Inc.

Analyst Recommendations

The next table highlights the given recommendations and ratings for AbbVie Inc. and Eli Lilly and Company.

AbbVie Inc.s consensus target price is $80.75, while its potential upside is 7.47%. On the other hand, Eli Lilly and Companys potential upside is 19.24% and its consensus target price is $129.33. The information presented earlier suggests that Eli Lilly and Company looks more robust than AbbVie Inc. as far as analyst view.

Insider and Institutional Ownership

Roughly 71% of AbbVie Inc. shares are owned by institutional investors while 83.7% of Eli Lilly and Company are owned by institutional investors. Insiders owned roughly 0.1% of AbbVie Inc.s shares. Competitively, Eli Lilly and Company has 12.1% of its share owned by insiders.

Performance

Here are the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

For the past year AbbVie Inc.s stock price has bigger decline than Eli Lilly and Company.

Summary

On 11 of the 15 factors Eli Lilly and Company beats AbbVie Inc.

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company offers HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; IMBRUVICA, an oral therapy for the treatment of patients with chronic lymphocytic leukemia; and VIEKIRA PAK, an interferon-free therapy, with or without ribavirin, for the treatment of adults with genotype 1 chronic hepatitis C. It also provides Kaletra, an anti- human immunodeficiency virus(HIV)-1 medicine used with other anti-HIV-1 medications as a treatment that maintains viral suppression in HIV-1 patients; Norvir, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1; and Synagis to prevent RSV infection at-risk infants. In addition, the company offers AndroGel, a testosterone replacement therapy for males diagnosed with symptomatic low testosterone; Creon, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid to treat hypothyroidism; and Lupron, a product for the palliative treatment of prostate cancer, endometriosis, and central precocious puberty, as well as for the treatment of patients with anemia. Further, it provides Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinsons disease; Sevoflurane, an anesthesia product for human use; and ZINBRYTA, a subcutaneous treatment for relapsing forms of multiple sclerosis. The company sells its products to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from its distribution centers and public warehouses. AbbVie Inc. has collaboration agreements with C2N Diagnostics; Calico Life Sciences LLC; Infinity Pharmaceuticals, Inc.; M2Gen; and Principia Biopharma Inc. The company was incorporated in 2012 and is based in North Chicago, Illinois.

Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. It operates through two segments, Human Pharmaceutical Products and Animal Health Products. The company offers endocrinology products to treat diabetes; osteoporosis in postmenopausal women and men; human growth hormone deficiency and pediatric growth conditions; and testosterone deficiency. It also provides neuroscience products for the treatment of depressive disorders, diabetic peripheral neuropathic pain, anxiety disorders, fibromyalgia, and chronic musculoskeletal pain; schizophrenia; attention-deficit hyperactivity disorders; depressive, obsessive-compulsive, bulimia nervosa, and panic disorders; and positron emission tomography imaging of beta-amyloid neurotic plaques in adult brains. In addition, the company offers products to treat non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and cardiovascular products to treat erectile dysfunction and benign prostatic hyperplasia; and migraine headaches. Further, it provides animal health products, such as cattle feed additives; protein supplements for cows; leanness and performance enhancers for swine and cattle; antibiotics to treat respiratory and other diseases in cattle, swine, and poultry; anticoccidial agents for poultry; and chewable tablets that kill fleas and prevent flea infestations, and heartworm diseases, as well as controls intestinal parasite infections. Additionally, the company offers vaccinev to prevent Lyme disease, bronchial infections, rabies, and various infectious diseases in dogs, cats, and horses. It has collaboration agreements with Daiichi Sankyo Co., Ltd., Incyte Corporation, Pfizer Inc., AstraZeneca, William Sansum Diabetes Center, Purdue University, and Nektar Therapeutics. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Read more:
Reviewing AbbVie Inc. (ABBV)'s and Eli Lilly and Company (NYSE:LLY)'s results - MS Wkly

Posted in Testosterone | Comments Off on Reviewing AbbVie Inc. (ABBV)’s and Eli Lilly and Company (NYSE:LLY)’s results – MS Wkly

Global Testosterone Replacement Therapy Market Growth Analysis, Forecasts to 2025: AbbVie, Endo International, Eli lilly, Pfizer, Actavis, Bayer – PR…

Posted: October 17, 2019 at 7:44 am

Report Testosterone Replacement Therapy covers all aspects of the "Testosterone Replacement Therapy Market". It provides basic market terminology and advanced analytical information in an understandable way that can be interpreted not just by a specialist but also a layman. One of the most important descriptions in this report is full information on the major key players AbbVie, Endo International, Eli lilly, Pfizer, Actavis (Allergan), Bayer, Novartis, Teva, Mylan, Upsher-Smith, Ferring Pharmaceuticals, Kyowa Kirin, Acerus Pharmaceuticals holding the market share. The information includes the company profile, annual turnover, the types of products and services they provide, income generation, which provide direction to businesses to take important steps.

Click here to access the Sample report: https://www.reportsbuzz.com/request-for-sample.html?repid=62240

The market growth rate in around the globe can vary from region to region, for which the report presents the full analysis based on different geographic areas. Information on the technical tactics that are followed in the market, applications are provided exclusively in the Testosterone Replacement Therapy report. At the same time, the report provides data analyzed based on cost structure statistics for raw material collection, efficient product manufacturing, safe delivery, and overall after-sales costs.

The global Testosterone Replacement Therapy report also contains detailed information on important, less significant growth and limitation factors that significantly affect market growth. The strike of the global Testosterone Replacement Therapy market is mentioned in the part of those areas, It demonstrates various segments Gels, Injections, Patches, Other and sub-segments Hospitals, Clinics, Others of the global Testosterone Replacement Therapy market. The report also provides comprehensive information on the income of top market owners, their annual transactions, the stability of their actions and the strategies used to attract the activity. The report also highlights some of the rules and regulations that have been established by the governing bodies of some countries that can stimulate and restrict commercial activities in certain parts of the world.

Read Detailed Index of full Research Study at:: https://www.reportsbuzz.com/62240/global-testosterone-replacement-therapy-market-outlook-2018-2025/

The information available in the Testosterone Replacement Therapy market summarized report provide customers with effective information that enables them to make effective decisions, which could lead to a significant expansion of the business in the future.

There are 15 Chapters to display the Global Testosterone Replacement Therapy market

Chapter 1, Definition, Specifications and Classification of Testosterone Replacement Therapy , Applications of Testosterone Replacement Therapy , Market Segment by Regions;Chapter 2, Manufacturing Cost Structure, Raw Material and Suppliers, Manufacturing Process, Industry Chain Structure;Chapter 3, Technical Data and Manufacturing Plants Analysis of Testosterone Replacement Therapy , Capacity and Commercial Production Date, Manufacturing Plants Distribution, R&D Status and Technology Source, Raw Materials Sources Analysis;Chapter 4, Overall Market Analysis, Capacity Analysis (Company Segment), Sales Analysis (Company Segment), Sales Price Analysis (Company Segment);Chapter 5 and 6, Regional Market Analysis that includes United States, China, Europe, Japan, Korea & Taiwan, Testosterone Replacement Therapy Segment Market Analysis (by Type);Chapter 7 and 8, The Testosterone Replacement Therapy Segment Market Analysis (by Application) Major Manufacturers Analysis of Testosterone Replacement Therapy ;Chapter 9, Market Trend Analysis, Regional Market Trend, Market Trend by Product Type Gels, Injections, Patches, Other, Market Trend by Application Hospitals, Clinics, Others;Chapter 10, Regional Marketing Type Analysis, International Trade Type Analysis, Supply Chain Analysis;Chapter 11, The Consumers Analysis of Global Testosterone Replacement Therapy ;Chapter 12, Testosterone Replacement Therapy Research Findings and Conclusion, Appendix, methodology and data source;Chapter 13, 14 and 15, Testosterone Replacement Therapy sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source.

Enquire Here Get customization & check discount for report @: https://www.reportsbuzz.com/inquiry-for-buying.html?repid=62240

Sorry! The Author has not filled his profile.

Read more from the original source:
Global Testosterone Replacement Therapy Market Growth Analysis, Forecasts to 2025: AbbVie, Endo International, Eli lilly, Pfizer, Actavis, Bayer - PR...

Posted in Testosterone | Comments Off on Global Testosterone Replacement Therapy Market Growth Analysis, Forecasts to 2025: AbbVie, Endo International, Eli lilly, Pfizer, Actavis, Bayer – PR…

Testosterone Replacement Therapy Market Examined in New Research Report – Midnight Stocks

Posted: October 16, 2019 at 4:49 pm

The globalTestosterone Replacement Therapy marketrides on the back of technology. As consumer focus shifts from access to comfort, players in the market for Testosterone Replacement Therapy are looking at new opportunities to capitalize on the potential. This exclusive report from Transparency Market Research will take you through an extensive analysis of every aspect in the Testosterone Replacement Therapy market that is critical for defining your success strategy. It offers prudent information on markets under currents, trends that will open new doors, factors that will remain important, challenges that need to be overcome, prevailing competition in the market, and the geographical landscape.

Based on a tested and proven research methodology, our research analysts bring to you fact-checked information. Besides presenting the current market figures, our analysts provide you with accurate forecasts that can be the game-changer for your winning strategies for tomorrow. On the other hand, our reports also offer tailor-made insights. Further, our reports are packed with experts viewpoints which are transcribed from interviews conducted by our analysts.

For every market, information on leading players can be the difference between success and failure, be it a prominent brand or not. Our reports cover every significant players in the global Testosterone Replacement Therapy market providing information about the company profile, products, winning strategies and market revenues. Not just that, TMR also provides information on the competitive landscape, helping you understand what impacted in one company being the market leader and others not. It also explains on the companies imperatives that define their success in the global market for Testosterone Replacement Therapy.

To obtain all-inclusive information on forecast analysis of Testosterone Replacement Therapy Market,Request a PDF Brochure Here

Healthcare, unlike most industries, is typical of the region. Humans have multiple races and hence their genetic makeups are different. As a result, one condition has different impacts depending on the region. Therefore, information on how consumer requirements are different in regional landscape of the global Testosterone Replacement Therapy market is provided her in the report. Further, the economic capabilities of a country has a huge impact on healthcare infrastructure. TMRs report analysis the current economic scenario and also brings to you information on affordability during the coming years.

From market share to region-specific strategies, the report covers it all. At the same time, players in the Testosterone Replacement Therapy market who are looking to expand might want to assess the potential of a prospective region. Our reports can provide you with custom-made insights for specific regions in the global Testosterone Replacement Therapy market. The geographical analysis also covers regions-specific factors that could turn out to be hurdle for growth in the coming years.

Read the rest here:
Testosterone Replacement Therapy Market Examined in New Research Report - Midnight Stocks

Posted in Testosterone | Comments Off on Testosterone Replacement Therapy Market Examined in New Research Report – Midnight Stocks

Hormone therapy clinics could be putting patients in danger – CBS News

Posted: October 15, 2019 at 8:44 pm

Medical clinics across the country are advertising a treatment some believe is a fountain of youth. They're selling hormone therapy as a way to make people look and feel younger. But a CBS News investigation finds this may be putting patients at risk.

Last year, at the age of 60, Cindy Kinder-Binge was rushed to a hospital in New Albany, Indiana, with a heart rate four times normal. Two months earlier, she had gone to the emergency room with palpitations.

"A cardiologist walks in and he said, 'Who put you on thyroid medicine?'" Kinder-Binge said.

She had been prescribed a thyroid hormone for menopausal symptoms like hot flashes, even though her thyroid blood levels were normal. She says her cardiologist had her stop taking the hormone because he believed it contributed to her irregular heartbeat.

She was treated by a nurse practitioner at a clinic called 25 Again. Hormone therapy is promoted as a way to help patients lose weight and feel younger. But a CBS News investigation found there are clinics across the country prescribing hormones like thyroid and testosterone to people with normal levels and it's not just 25 Again.

Ultrasound technician Leighann Decker is a former employee of an OB-GYN in Owensboro, Kentucky. The doctor Decker worked for prescribed testosterone to patients with normal testosterone levels looking to turn back the clock.

"More and more practitioners have tried to jump on board and when they've seen the profit that's being made from it. Of course, it's cash pay. It's easy money," Decker said.

The doctor in Kentucky and the practitioner in Indiana both attended seminars given by Dr. Neal Rouzier. He has been promoting hormone replacement therapy for decades and said he's trained thousands of clinicians around the world. During a 2016 deposition, he said he gives testosterone to patients even if their levels are normal.

"I don't care about the number. I treat patients. I treat symptoms," Rouzier said.

Some research suggests testosterone therapy may increase the risk of heart attack or stroke. In 2015, Rouzier dismissed that concern.

"There's thousands of articles to show protection against heart attacks," he said.But under oath, in that deposition, he was unable to point to any evidence that would back up his claim that his approach to testosterone therapy is safe.

"The problem is that there is no fountain of youth," said Dr. Steven Nissen, a cardiologist at the Cleveland Clinic. Nissen is leading an FDA-mandated study to see if giving testosterone affects the risk of heart attack or stroke in men with low levels."There's no scientific basis for giving hormone therapy to people whose levels are already normal and there's lots of suggestions that it may actually be harmful," Nissen said.

Kinder-Binge is suing 25 Again. The company told CBS News the overall health of their patients is their priority and they make patients aware of any risks. Rouzier declined our request for an interview and did not respond to a list of written questions.

2019 CBS Interactive Inc. All Rights Reserved.

See original here:
Hormone therapy clinics could be putting patients in danger - CBS News

Posted in Testosterone | Comments Off on Hormone therapy clinics could be putting patients in danger – CBS News

Page 60«..1020..59606162..»